BIOTECH: HALOZYME GETS CREATIVE IN PURSUIT OF CASH
Biotech Financing
Originally published July 7, 2016 at 11:40 a.m., updated July 7, 2016 at 11:40 a.m.
Research scientist Li Zhu works in the lab at Halozyme Inc., which is developing drugs that target cancer. Photo by Melissa Jacobs.
San Diego In today’s market, with valuations down and investors wary, it’s critical for biotechs to get creative when looking for cash to fuel research...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in

- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know